Tagged Articles

celebrity chef 17 articles

Novo Nordisk tests high doses of diabetes drug Victoza as weight loss treatment

Drug maker Novo Nordisk is testing high doses of its type 2 diabetes drug Victoza as a possible treatment for obesity. However, analysts are questioning whether it will work well enough to be a commercial success. Victoza was initially marketed by Novo Nordisk using celebrity chef Paula Deen. The company quickly discontinued the contract with Deen after the Southern chef was heavily criticized for making racist remarks. The drug is in a class of medications known as glucagon-like peptide 1 dugs, or GLP-1. Other drugs in this group include Byetta, made by Bristol-Myers Squibb and AstraZeneca. GLP-1 drugs are in ... Read More

Type 2 diabetes drug Victoza may improve vascular health but poses cancer risk

Victoza, a type 2 diabetes treatment that works to regulate glucose, may improve the condition of arteries and possibly protect against heart attack or stroke, a new report shows. However, that benefit will have to be weighed against the drug’s cancer risks. Victoza, also known as liragliutide, is an injection made by Novo Nordisk to treat high blood sugar in type 2 diabetics. Many people may be familiar with the drug’s former spokesperson, celebrity chef Paula Deen, who after accepting the company’s offer to front their drug, admitted she was diagnosed with type 2 diabetes two years prior. She has ... Read More

Will Novo Nordisk be the next company to drop Paula Deen for making racist comments?

Celebrity Chef Paula Deen’s confession that she has used the “N word” and told jokes that could be perceived as racist during a video deposition as part of a $1.2 million lawsuit filed against her by a former employee has landed her in a mess of trouble and it seems she just can’t bail herself out. When trying to rationalize why she told racial jokes she replied, “It’s just what they are – they’re jokes… most jokes are about Jewish people, rednecks, black folks…Gays or straights, black, redneck, you know. I just don’t know – I just don’t know what ... Read More

A year after diabetes diagnosis, Paula Deen introduces new line of ‘finishing butters’

Paula Deen, Food Network’s Southern belle of high-fat, sugary recipes, is putting her face and name on packages of flavored butters. Paula Deen’s finishing butters will be sold at Wal-Mart stores across the country, and beg the question whether Paula is more serious about promoting healthy eating since revealing her type 2 diabetes diagnosis last year, or about making money from sales of somewhat unhealthy products. The celebrity chef and cookbook author admits she kept her type 2 diabetes diagnosis hidden for three years – meanwhile continuing to prepare high-fat and sugary recipes on her TV show – until drug ... Read More

Novo Nordisk testing higher doses of Victoza as weight loss drug for obese diabetics

Novo Nordisk is hoping data from a phase III trial involving a higher dosage of its type 2 diabetes drug Victoza (liraglutide) will show it can help overweight and obese people with the chronic disease lose weight. The first of three studies in the pharmaceutical company’s SCALE clinical program showed promising results. Patients given a high (3mg) dose achieved a 6 percent reduction in weight compared to a 2 percent reduction in patients taking a placebo. Victoza is already approved in 1.8 mg dosage, and previous studies have shown the drug can reduce weight in patients by 5 percent. The ... Read More

FDA requires more data on cardiovascular risks with Novo Nordisk’s new diabetes medications

Novo Nordisk must complete a clinical trial on the cardiovascular effects of its long-acting insulin degludec drugs and correct deficiencies at its primary manufacturing plant before the Food and Drug Administration (FDA) will clear the new diabetes drugs for sale in the U.S. The drug company was hoping for a more favorable response on its insulin Tresiba (degludec) and its combination product Ryzodeg (degludec and insulin aspart). The drugs would be the only insulin drugs indicated for once-daily, anytime dosing. Approval seemed likely based on a November 2012 review by an FDA advisory panel. The group voted to recommend approval but ... Read More

Paula Deen reveals weight loss strategies in new cookbook

Celebrity chef Paula Deen says she and her family have lost a total of 178 pounds since she went on national TV last year and announced she was diagnosed two years prior with type 2 diabetes. The news garnered much criticism since Deen is known for her Southern deep fried, butter coated, and heavily creamed recipes – the kinds of unhealthy foods that cause weight gain and put people at risk for type 2 diabetes. Even more controversial is that Deen didn’t come forward with her diagnosis until she was offered a handsome paycheck by drug company Novo Nordisk to ... Read More

Paula Deen and sons team up with drug maker to push recipes for diabetics

Paula Deen and her two sons, Bobby and Jamie, are teaming up with drug maker Novo Nordisk for a national initiative aimed at helping diabetics like Paula overcome common challenges associated with type 2 diabetes management. The campaign, called Diabetes in a New Light, features recipes for lighter versions of some of Paula’s favorite summertime recipes. Earlier this year, Paula announced she had been diagnosed with type 2 diabetes three years prior. She chose to come clean about her disease after signing a lucrative deal with Novo Nordisk to promote its type 2 diabetes drug Victoza. The celebrity chef’s announcement ... Read More

Paula Deen’s deal with diabetes drug among ‘Most Questionable’ celebrity chef deals

Huffington Post has named Paula Deen’s deal to promote a type 2 diabetes drug among “The 13 Most Questionable Deals” made by celebrity chefs. “Everyone has to make a living, even celebrity chefs. That disclaimer aside, the last few years have seem more than a few celebrity chef endorsements that raise an eyebrow or three,” the publication reported. “We hear about the most egregious ones in the press – like butter-evangelist Paula Deen’s deal with a diabetes medication that went public just after she announced her own diabetes diagnosis…” Deen’s decision to come clean about her type 2 diabetes diagnosis three ... Read More

Paula Deen’s diabetes drug of choice brings in hearty profits

Danish pharmaceutical company Novo Nordisk is rolling in profits, thanks to strong sales of its new diabetes drugs. Novo Nordisk is the world’s largest insulin manufacturer. It also makes non-insulin medications to treat type 2 diabetes including Victoza, a new treatment that is being promoted by Southern celebrity cookbook author Paula Deen. Deen caught a lot of flack when she announced earlier this year that she had been diagnosed three years ago with type 2 diabetes. Deen’s Southern-fried and sugar-filled recipes are prime examples of the kinds of foods that contribute to the country’s growing obesity and diabetes epidemic. But ... Read More